These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 24142802)

  • 21. Persistence patterns with oral antidiabetes drug treatment in newly treated patients--a population-based study.
    Grégoire JP; Sirois C; Blanc G; Poirier P; Moisan J
    Value Health; 2010; 13(6):820-8. PubMed ID: 21054658
    [TBL] [Abstract][Full Text] [Related]  

  • 22. First-year treatment adherence among outpatients initiating antihypertensive medication in Korea: results of a retrospective claims review.
    Sung SK; Lee SG; Lee KS; Kim DS; Kim KH; Kim KY
    Clin Ther; 2009 Jun; 31(6):1309-20. PubMed ID: 19695396
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of once-daily and twice-daily dosing on adherence with prescribed glipizide oral therapy for type 2 diabetes.
    Dezii CM; Kawabata H; Tran M
    South Med J; 2002 Jan; 95(1):68-71. PubMed ID: 11827247
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Compliance and persistence with concomitant statin and oral antihyperglycemic therapy.
    Zhang Q; Zhao C; Davies MJ; Radican L; Seck T
    Am J Manag Care; 2011 Nov; 17(11):746-52. PubMed ID: 22084894
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The prevalence and ingredient cost of chronic comorbidity in the Irish elderly population with medication treated type 2 diabetes: a retrospective cross-sectional study using a national pharmacy claims database.
    O'Shea M; Teeling M; Bennett K
    BMC Health Serv Res; 2013 Jan; 13():23. PubMed ID: 23324517
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Does antidepressant medication use affect persistence with diabetes medicines?
    Caughey GE; Preiss AK; Vitry AI; Gilbert AL; Ryan P; Shakib S; Esterman A; McDermott RA; Roughead EE
    Pharmacoepidemiol Drug Saf; 2013 Jun; 22(6):615-22. PubMed ID: 23447430
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacy-based predictors of non-persistence with and non-adherence to statin treatment among patients on oral diabetes medication in the Netherlands.
    Alfian SD; Worawutputtapong P; Schuiling-Veninga CCM; van der Schans J; Bos JHJ; Hak E; Denig P
    Curr Med Res Opin; 2018 Jun; 34(6):1013-1019. PubMed ID: 29292657
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adherence, Persistence, and Switching Among People Prescribed Sodium Glucose Co-transporter 2 Inhibitors: A Nationwide Retrospective Cohort Study.
    Ofori-Asenso R; Liew D; Lalic S; Mazidi M; Magliano DJ; Ademi Z; Bell JS; Ilomaki J
    Adv Ther; 2019 Nov; 36(11):3265-3278. PubMed ID: 31482509
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Initial and subsequent therapy for newly diagnosed type 2 diabetes patients treated in primary care using data from a vendor-based electronic health record.
    Brouwer ES; West SL; Kluckman M; Wallace D; Masica AL; Ewen E; Kudyakov R; Cheng D; Bowen J; Fleming NS
    Pharmacoepidemiol Drug Saf; 2012 Sep; 21(9):920-8. PubMed ID: 22250059
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Brand name or generic? What are the health professionals prescribed for treating diabetes? A longitudinal analysis of the National Health Insurance reimbursement database.
    Liou WS; Hsieh SC; Chang WY; Wu GH; Huang HS; Lee C
    Pharmacoepidemiol Drug Saf; 2013 Jul; 22(7):752-9. PubMed ID: 23625864
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mail-order pharmacy use and medication adherence among Medicare Part D beneficiaries with diabetes.
    Zhang L; Zakharyan A; Stockl KM; Harada AS; Curtis BS; Solow BK
    J Med Econ; 2011; 14(5):562-7. PubMed ID: 21728913
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Refill compliance in type 2 diabetes mellitus: a predictor of switching to insulin therapy?
    Spoelstra JA; Stolk RP; Heerdink ER; Klungel OH; Erkens JA; Leufkens HG; Grobbee DE
    Pharmacoepidemiol Drug Saf; 2003 Mar; 12(2):121-7. PubMed ID: 12642975
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oral antidiabetic therapy in a large Italian sample: drug supply and compliance for different therapeutic regimens.
    Vittorino Gaddi A; Benedetto D; Capello F; Di Pietro C; Cinconze E; Rossi E; De Sando V; Cevenini M; D'Alò G
    Public Health; 2014 Jan; 128(1):70-6. PubMed ID: 23969148
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacy effect on adherence to antidiabetic medications.
    Sharma KP; Taylor TN
    Med Care; 2012 Aug; 50(8):685-91. PubMed ID: 22354211
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adherence to a fixed-dose combination of rosiglitazone maleate/metformin hydrochloride in subjects with type 2 diabetes mellitus: a retrospective database analysis.
    Vanderpoel DR; Hussein MA; Watson-Heidari T; Perry A
    Clin Ther; 2004 Dec; 26(12):2066-75. PubMed ID: 15823770
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The relationship of guideline-concordant depression treatment and patient adherence to oral diabetes medications.
    Nau DP; Chao J; Aikens JE
    Res Social Adm Pharm; 2005 Sep; 1(3):378-88. PubMed ID: 17138485
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Persistence with injectable antidiabetic agents in members with type 2 diabetes in a commercial managed care organization.
    Cooke CE; Lee HY; Tong YP; Haines ST
    Curr Med Res Opin; 2010 Jan; 26(1):231-8. PubMed ID: 19921965
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Predictors of adherence among Alzheimer's disease patients receiving oral therapy.
    Borah B; Sacco P; Zarotsky V
    Curr Med Res Opin; 2010 Aug; 26(8):1957-65. PubMed ID: 20569067
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Depression in patients with type 2 diabetes: impact on adherence to oral hypoglycemic agents.
    Kalsekar ID; Madhavan SS; Amonkar MM; Makela EH; Scott VG; Douglas SM; Elswick BL
    Ann Pharmacother; 2006 Apr; 40(4):605-11. PubMed ID: 16551768
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lower risk of major cardiovascular events associated with adherence to colesevelam HCI.
    Ye X; Qian C; Liu J; St Peter WL
    Pharmacotherapy; 2013 Oct; 33(10):1062-70. PubMed ID: 23798059
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.